Clinical Trial Results
Search
Dr. James Ampadu and Dr. C. Michael Gibson discuss: Transthyretin tetramer destabilization and increased mortality, and the physiologic importance of TTR.
Disclosures: Sponsored by BridgeBio Pharma, Inc.
Dr. Richard Wright and Dr. C. Michael Gibson discuss: Transthyretin tetramer destabilization and increased mortality, and the physiologic importance of TTR.
Disclosures: Sponsored by BridgeBio Pharma, Inc
Dr. Joshua Mitchell and Dr. C. Michael Gibson discuss: Transthyretin tetramer destabilization and increased mortality, and the physiologic importance of TTR.
Disclosures: Sponsored by BridgeBio Pharma, Inc.
Dr. M. Trejeeve Martyn and Dr. C. Michael Gibson discuss: The importance of early screening, diagnosis, and treatment for ATTR-CM
Disclosures: Sponsored by BridgeBio Pharma, Inc.
THIS WEEK IN OBESITY
Participants randomized to the placebo arm in obesity trials often do not lose weight and as a result may drop out […]
THIS WEEK IN OBESITY
Dr. Javed Butler and Dr. C. Michael Gibson discuss the flaws of BMI in obesity trials
#Thisweekinmedicine
Dr. Shinya Goto and I discuss the vexing problem of antiplatelet and anticoagulant therapy in patients with hereditary clotting disorders like hemophilia.
THIS WEEK IN OBESITY
Dr. Javed Butler and I discuss the flaws of BMI in obesity trials